Behind a personalized therapy with immune check-point inhibitors in metastatic bladder cancer: ready for a primetime?

ABSTRACT:

SUBMITTER: Poletajew S 

PROVIDER: S-EPMC7807308 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature